Literature DB >> 2649262

Malignant cell glycoproteins and glycolipids.

J A Alhadeff1.   

Abstract

The cell surface is involved in cell growth and division, cell-cell interaction, communication, differentiation and migration, and other processes likely to be involved in malignant transformation and/or the metastatic spread of cancer. Although there are many alterations of glycoproteins and glycolipids on the malignant cell surface, it is unclear whether these alterations are epiphenomena or an integral part of the malignancy process. This article reviews the recent literature and some earlier studies relevant for understanding emerging concepts and trends with respect to malignant cell glycoconjugates. Emphasis is on structural alterations of the carbohydrate portions of malignant cell glycoproteins and glycolipids and on the enzymes (glycosyltransferases and glycosidases) involved in their metabolism. Practical applications derived from malignant cell glycoconjugate studies are discussed briefly with respect to the diagnosis, staging, monitoring, and treatment of malignant disease. The review concludes by indicating which research areas on malignant cell glycoconjugates are likely to be fruitful in increasing our basic understanding of, and ability to deal effectively with, malignant disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649262     DOI: 10.1016/s1040-8428(89)80014-9

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  12 in total

Review 1.  [Tumor lectinology--status and perspectives of clinical application].

Authors:  H J Gabius; S Gabius
Journal:  Naturwissenschaften       Date:  1990-11

Review 2.  CD44 in inflammation and metastasis.

Authors:  J Lesley; R Hyman; N English; J B Catterall; G A Turner
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

3.  Sialyltransferase activity in FR3T3 cells transformed with ras oncogene: decreased CMP-Neu5Ac:Gal beta 1-3GalNAc alpha-2,3-sialyltransferase.

Authors:  P Delannoy; H Pelczar; V Vandamme; A Verbert
Journal:  Glycoconj J       Date:  1993-02       Impact factor: 2.916

4.  Characterization of deoxyguanosine-resistant hypoxanthine-guanine phosphoribosyltransferase(-)metastatic variants altered in soybean-agglutinin-binding properties and cell-surface glycoproteins.

Authors:  J E Damen; M A Spearman; A H Greenberg; J A Wright
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Assessment of serum L-fucose in brain tumor cases.

Authors:  S Manjula; Flama Monteiro; Annaya Rao Aroor; Suryanarayan Rao; Raja Annaswamy; Anjali Rao
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

Review 6.  Tumor galectinology: insights into the complex network of a family of endogenous lectins.

Authors:  Harald Lahm; Sabine André; Andreas Hoeflich; Herbert Kaltner; Hans-Christian Siebert; Bernard Sordat; Claus-Wilhelm von der Lieth; Eckhard Wolf; Hans-Joachim Gabius
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

7.  Clinical usefulness of alterations in sialic acid, sialyl transferase and sialoproteins in breast cancer.

Authors:  G N Raval; L J Parekh; D D Patel; F P Jha; R N Sainger; P S Patel
Journal:  Indian J Clin Biochem       Date:  2004-07

8.  Lipid-associated sialic acid levels in human breast cyst fluids.

Authors:  F Mannello; G Bocchiotti; R Troccoli; G Gazzanelli
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 9.  [Protein-carbohydrate recognition. Foundation and medical application with illustrations of tumor lectin studies].

Authors:  H J Gabius; K Kayser; S Gabius
Journal:  Naturwissenschaften       Date:  1995-12

10.  Neoglycoprotein binding to colorectal tumour cells: comparison between primary and secondary lesions.

Authors:  H J Gabius; T Grote; S Gabius; U Brinck; L F Tietze
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.